Cramer's Lightning Round: Exelixis is a 'good spec' – NBC New York
“Mad Money” host Jim Cramer rings the lightning round bell, which means he’s giving his answers to callers’ stock questions at rapid speed.
Source: nbcnewyork.com
📰 Cramer Twitter News
Page 27 - Cramer Twitter News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Cramer Twitter. Real-time updates on events, politics, business and more.
Cramer's Lightning Round: Exelixis is a 'good spec' – NBC10 Philadelphia
“Mad Money” host Jim Cramer rings the lightning round bell, which means he’s giving his answers to callers’ stock questions at rapid speed.
Source: nbcphiladelphia.com
What to look for when the major banks report earnings, according to Jim Cramer
CNBC’s Jim Cramer has an eye toward Friday’s earnings reports from JPMorgan, Bank of America, Citigroup and Wells Fargo.
Source: nbcdfw.com
Jim Cramer says positive analyst notes hold real power in this market
CNBC’s Jim Cramer said today’s market is heavily impacted by analyst upgrades and price target bumps.
Source: nbcdfw.com
Cramer's Lightning Round: 'Let's take a pass' on Lithium Americas – NBC Connecticut
“Mad Money” host Jim Cramer rings the lightning round bell, which means he’s giving his answers to callers’ stock questions at rapid speed.
Source: nbcconnecticut.com
Cramer's Lightning Round: 'Let's take a pass' on Lithium Americas – NBC New York
“Mad Money” host Jim Cramer rings the lightning round bell, which means he’s giving his answers to callers’ stock questions at rapid speed.
Source: nbcnewyork.com
Jim Cramer says the market needs a solid earnings season after Thursday's hotter-than-expected inflation numbers
CNBC’s Jim Cramer bemoaned Thursday’s hotter-than-expected inflation figures for December.
Source: nbcmiami.com
CVS CEO touts expanding primary care health services after major acquisitions
In a Tuesday interview with CNBC’s Jim Cramer, CVS CEO Karen Lynch discussed her company’s expansion into primary care.
Source: nbcdfw.com
Regeneron CEO says the next big thing for biotech isn't AI, it's gene therapy
Regeneron CEO Leonard Schleifer detailed the biotech company’s newest ventures in the pharmaceutical industry.
Source: nbcnewyork.com
Cramer says today's market is more interested in AI technology for advertising, not health-care solutions
CNBC’s Jim Cramer on Tuesday said Wall Street is more is more concerned with using AI for advertising purposes.
Source: nbcmiami.com